General (19) Acquisitions (3) New Products (1) Partnerships (1)
Pharma and Biotech (21) Bioscience (2) Corporate (2)
2017 (21)
English (21)
2017X
EnglishX
Showing 1‐20 of 21
results per page
14 Dec 2017
Serialization Capabilities Now Operational at Lonza Edinburgh Facility for Liquid-Filled Hard Capsules
Counterfeit and diverted medicines are a growing threat to patientsInvestment in former Capsugel site improves anti-counterfeiting security for...
30 Nov 2017
Lonza, Akouos and MEE Announce Strategic Gene Therapy License Agreements on Hearing and Balance Disorders
Lonza and Massachusetts Eye and Ear (MEE) grant Akouos exclusive licenses to proprietary ancestral AAV (Anc-AAV) vectors for all hearing and...
08 Nov 2017
Lonza Launches XS™ Pichia 2.0 Expression and Manufacturing Platform for Development of Next Generation Therapeutics
System designed to provide high product titers up to 6 g/LFermentation strategy that results in drastically-reduced fermentation timesAvailable...
02 Nov 2017
Lonza Expands Service Offerings for Early Phase Biopharmaceutical Drug Development
Protein Sequence Variant Analysis de-risks clinical candidatesSite-Specific Conjugation Vectors for GS Xceed® System support expression of...
09 Oct 2017
Lonza Announces Formation of New Research and Development Collaborative Innovation Center in Israel
Basel, Switzerland, 9 October 2017 – Lonza today announced the establishment of the Lonza Collaborative Innovation Center (CIC) in the new Life...
05 Oct 2017
Lonza Cell & Gene Therapy Manufacturing Facility in Houston, TX, Area to Complete Construction on Schedule in 2017
Pearland, TX (USA), site will be the world's largest facility dedicated to cell and gene therapy development and manufacturingBasel, Switzerland, 5...
03 Oct 2017
Lonza to Acquire a U.S. Clinical Manufacturing Site to Support Ongoing Customer Demand
Site is being acquired from Shire plc and adds early-phase clinical manufacture on the West CoastCapacity includes 1,000L and 2,000L single-use...
05 Sep 2017
Lonza and Portola Pharmaceuticals Sign Strategic Long-Term Manufacturing Agreement to Secure Supply of AndexXa ®
Basel, Switzerland, 5 September 2017 – Lonza, a global leader in chemical and biological manufacturing, today announced that it has entered into a...
31 Aug 2017
Lonza's Houston Sites Experience Minimal Impact from Hurricane Harvey
Basel, Switzerland, 31 August 2017 – We are currently assessing the changing situation in Houston, TX (USA) following Hurricane Harvey. Most...
24 Aug 2017
Lonza to Increase and Expand Capabilities for Drug Product Services for Parenteral Dosage Forms
Operational since November 2016, Drug Product Services will expand their facility in Basel (CH) and increase capacity for existing services...
15 Aug 2017
Lonza Expands Support for Researchers with New Endothelial Cell Application Center
Walkersville, MD (USA) / Basel, Switzerland, 15 August 2017 – Today Lonza announced an endothelial cell application center, which expands Lonza’s...
26 Jul 2017
Lonza Pharma&Biotech Launches Ibex™ Solutions – An Innovative New Concept in Biological Manufacturing and Development
Visp, Switzerland, 26 July 2017 – Lonza’s commitment to constant innovation and adding value to its customers and partners is today demonstrated by...
30 May 2017
Lonza Acquires Cell and Gene Contract Manufacturer PharmaCell
Basel, Switzerland, 30 May 2017 – On 3 May 2017, Lonza successfully completed the acquisition of PharmaCell B.V., one of the most-respected cell...
16 May 2017
Lonza Invests to Develop Exosomes for Next-Generation Life-Science Applications
Lonza has acquired HansaBioMed Life Sciences and has invested into Exosomics Siena to develop next-generation research, therapeutic and diagnostic...
28 Apr 2017
Lonza to Host Webinar: "The Importance of Data Integrity for Endotoxin Testing"
Cologne, DE / Walkersville, MD (USA), 28 April 2017 – Lonza is hosting a free 60-minute webinar on 9 May 2017 emphasizing the importance of data...
27 Apr 2017
Lonza Celebrates 10 Years as ADC Manufacturing Pioneers
Basel, Switzerland, 27 April 2017 – Lonza today announced that it is celebrating a decade of antibody drug conjugate (ADC) manufacturing under...
20 Apr 2017
Lonza Unveils Agenda for 3 rd Annual Global Endotoxin Testing Summit
Walkersville, MD (USA) / Basel, Switzerland, 20 April 2017 – A growing list of experts from the global bacterial endotoxin testing community has...
11 Apr 2017
Lonza to Host New Webinar: “Justifying a Paperless Solution – Building a Compelling Business Case”
Cologne (DE) / Walkersville, MD (USA), 11 April 2017 – Lonza is hosting a free 60-minute webinar on 25 April 2017 on how to create a compelling...
07 Mar 2017
Low Endotoxin Recovery (LER) White Paper Released to QC Insider™ Toolbox
Cologne, Germany / Basel, Switzerland, 07 March 2017 – Today Lonza announced the release of a new tool in the QC Insider™ Toolbox that provides the...
27 Feb 2017
Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility
The large-scale facility, to be built in Visp, Switzerland, will be established through a joint venture with an initial investment of around CHF...
1 2 >